… After Merck, Chinese Biotech Hengrui Pharma Collaborates With … of its Specialty Medicines and Vaccines divisions, coupled … acting injectable HIV treatment combining cabotegravir and rilpivirine, to be … potential effects of pharmaceutical product imports on …

… Medical Center and a director of the Tennessee Center of AIDS … that HBV screening and vaccination rates remain low. Currently … cabotegravir (CAB) and rilpivirine (RPV) for HIV treatment; however, CAB and … anesthesia in a normal doctor';s office by …

… Healthcare, a company focused on HIV medicines and majority owned by GSK … and Shionogi as shareholders, and Medicines Patent Pool, extending their voluntary … + rilpivirine as an HIV treatment option, the report said. [Read more: Aurobindo receives FDA …

… with the United Nations-backed Medicines Patent Pool (MPP) … who are virally suppressed. Rilpivirine, which was developed by … approved by the FDA as an HIV treatment in 2011 and already … which allowed specified generic drugmakers to produce their versions …

… long-acting injectable cabotegravir + rilpivirine as an HIV treatment option. Existing generic licensees … deeper and broader interest in HIV and AIDS than any company has … to deliver effective and innovative medicines for HIV treatment and prevention, as well …

… HIV elected to switch to long-acting injectable Vocabria + Rekambys (cabotegravir + rilpivirine … MBChB, MFPM, chief medical officer at ViiV Healthcare … trial is evaluating two 2-drug regimens for HIV-1 treatment … REKAMBYS FROM DAILY PILLS AFTER ACHIEVING RAPID …

… licensing agreement with the Medicines Patent Pool for cabotegravir … acting injectable cabotegravir + rilpivirine as an HIV treatment option. Existing generic licensees … Healthcare, Medicines Patent Pool provide access to HIV prevention medications] Charles …

… landscape of HIV care, ViiV Healthcare’s chief medical officer … acting therapies like cabotegravir plus rilpivirine (CAB + RPV LA)—a … show 89% of treatment-naïve people with HIV choose to switch …  Vocabria + Rekambys from daily pills after achieving rapid viral …

… of Cabenuva (cabotegravir and rilpivirine) has found that … presented at the International AIDS Society meeting in Kigali … to capture demographics, medical and treatment history, and clinical outcomes … continue with trials for this version. A trial of the …

… rilpivirine is as effective as dolutegravir-based oral treatment in adults with HIV … discontinued study drug due to drug-related adverse … hepatitis B vaccination according to national … trial 48-week results. 13th International AIDS Society Conference on HIV …